Premium
Development and characterization of a catalytically inactive cysteine protease domain of RtxA1/MARTX Vv as a potential vaccine for Vibrio vulnificus
Author(s) -
Lee Tae Hee,
Chung Kyung Min
Publication year - 2015
Publication title -
microbiology and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 70
eISSN - 1348-0421
pISSN - 0385-5600
DOI - 10.1111/1348-0421.12284
Subject(s) - vibrio vulnificus , biology , virulence , vibrio infections , cysteine protease , microbiology and biotechnology , protease , immunization , virology , vibrionaceae , bacteria , immune system , enzyme , genetics , biochemistry , gene
Recent studies have defined several virulence factors as vaccine candidates against Vibrio vulnificus . However, most of these factors have the potential to cause pathogenic effects in the vaccinees or induce incomplete protection. To overcome these drawbacks, a catalytically inactive form, CPD Vv (C3725S), of the well‐conserved cysteine protease domain (CPD) of V. vulnificus multifunctional autoprocessing repeats‐in‐toxin (MARTX Vv /RtxA1) was recombinantly generated and characterized. Notably, active and passive immunization with CPD Vv (C3725S) conferred protective immunity against V. vulnificus strains. These results may provide a novel framework for developing safe and efficient subunit vaccines and/or therapeutics against V. vulnificus that target the CPD of MARTX toxins.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom